Technical Analysis for ZYNE - Zynerba Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 13.18 -2.59% -0.35
ZYNE closed down 2.59 percent on Friday, May 24, 2019, on 60 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical ZYNE trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
MACD Bearish Signal Line Cross Bearish -2.59%
20 DMA Support Bullish -2.59%
Wide Bands Range Expansion -2.59%
Wide Bands Range Expansion -10.10%

Older signals for ZYNE ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on developing and commercializing synthetic cannabinoid therapeutics formulated for transdermal delivery. The Company has two product candidates, including ZYN002 and ZYN001, which represent cannabinoid therapeutics for several indications, including refractory epilepsy, Fragile X syndrome (FXS), osteoarthritis (OA), fibromyalgia and peripheral neuropathic pain. ZYN002 is a synthetic cannabidiol (CBD) formulated as a permeation-enhanced gel for transdermal delivery. In preclinical animal studies, ZYN002's permeation enhancer increased delivery of CBD through the layers of the skin and into the circulatory system. ZYN001 is a pro-drug of delta-9-tetrahydrocannabinol (THC) that enables transdermal delivery through a patch. In preclinical animal studies, ZYN001 demonstrated effective skin permeation with sustained delivery and rapid conversion of ZYN001 to THC.
Pharmaceutical Pain Drugs Chemical Compounds Osteoarthritis Psychoactive Drugs Entheogens Cannabidiol Cannabinoids Fibromyalgia Fragile X Syndrome
Is ZYNE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.47
52 Week Low 2.75
Average Volume 2,805,669
200-Day Moving Average 6.6525
50-Day Moving Average 9.7112
20-Day Moving Average 13.1375
10-Day Moving Average 14.173
Average True Range 1.2455
ADX 37.74
+DI 27.6725
-DI 20.2677
Chandelier Exit (Long, 3 ATRs ) 12.7335
Chandelier Exit (Short, 3 ATRs ) 13.3065
Upper Bollinger Band 15.6996
Lower Bollinger Band 10.5754
Percent B (%b) 0.51
BandWidth 39.004377
MACD Line 1.2988
MACD Signal Line 1.4786
MACD Histogram -0.1797
Fundamentals Value
Market Cap 174.73 Million
Num Shares 13.3 Million
EPS -2.60
Price-to-Earnings (P/E) Ratio -5.07
Price-to-Sales 0.00
Price-to-Book 1.77
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.21
Resistance 3 (R3) 15.39 14.89 14.87
Resistance 2 (R2) 14.89 14.38 14.80 14.75
Resistance 1 (R1) 14.04 14.06 13.79 13.86 14.64
Pivot Point 13.54 13.54 13.42 13.45 13.54
Support 1 (S1) 12.69 13.03 12.44 12.51 11.72
Support 2 (S2) 12.19 12.71 12.10 11.61
Support 3 (S3) 11.34 12.19 11.49
Support 4 (S4) 11.16